Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v2-FR
Language French French
Date Updated 2019-10-01 2019-01-17
Drug Identification Number 02382385 02382385
Brand name MIDAZOLAM INJECTION USP MIDAZOLAM INJECTION USP
Common or Proper name MIDAZOLAM MIDAZOLAM
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MIDAZOLAM MIDAZOLAM
Strength(s) 5MG 5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10 x 10mL GVL MD 10 x 10mL GVL MD
ATC code N05CD N05CD
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-03-15
Actual start date 2019-03-22
Estimated end date 2019-04-12
Actual end date 2019-09-10
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Current inventory is on preventative allocation.
Health Canada comments